Overview

• The DEA's latest threat assessment identifies Canadian fentanyl superlabs as an emerging concern, with potential for increased production.
• While Canada's fentanyl output remains far below Mexico's, U.S. officials warn of its capacity to expand.
• President Trump declared a northern border emergency in March and imposed tariffs on Canadian goods, partially exempting USMCA-compliant imports.
• The RCMP dismantled a major fentanyl lab in British Columbia in October 2024, highlighting Canada's role in synthetic opioid production.
• Canada has responded with measures like appointing a federal drug czar and enhancing border inspections, but U.S. officials deem these efforts insufficient.